(2s)-2-amino-n-[(2r)-1-[[2-[[(2s)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide (CED0054283)

Record Information
Version1.0
Creation Date2026-08-22 06:50:04 UTC
Update Date2026-08-22 06:50:04 UTC
Accession NumberCHEM210848
Identification
Common Name(2s)-2-amino-n-[(2r)-1-[[2-[[(2s)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide
ClassSmall Molecule
Description
(2s)-2-amino-n-[(2r)-1-[[2-[[(2s)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 513.60 g/mol, (2s)-2-amino-n-[(2r)-1-[[2-[[(2s)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide is a heavy molecule. Its chemical formula is C26H35N5O6.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC26H35N5O6
Average Molecular Mass513.600 g/mol
Monoisotopic Mass513.259 g/mol
CAS Registry Number78123-71-4
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C26H35N5O6/c1-17(30-25(36)21(27)14-19-8-10-20(33)11-9-19)24(35)29-16-23(34)31(2)22(26(37)28-12-13-32)15-18-6-4-3-5-7-18/h3-11,17,21-22,32-33H,12-16,27H2,1-2H3,(H,28,37)(H,29,35)(H,30,36)/t17-,21+,22+/m1/s1
InChI KeyHPZJMUBDEAMBFI-WTNAPCKOSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
5338.0Log mg/kg[3000:9500]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)193.689
Click to view 3D structureMu-type opioid receptorP97266Cavia porcellusPredicted (SEA)166.753
Click to view 3D structureDelta-type opioid receptorP33533Rattus norvegicusPredicted (SEA)143.476
Click to view 3D structureDelta-type opioid receptorP32300Mus musculusPredicted (SEA)166.052
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)219.613
Click to view 3D structureKappa-type opioid receptorP41144Cavia porcellusPredicted (SEA)153.83
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)191.353
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)200.228
Click to view 3D structureMu-type opioid receptorP42866Mus musculusPredicted (SEA)99.8806
Proenkephalin-B structureClick to view 3D structureProenkephalin-BP01213HumansPredicted (SEA)57.2192
Click to view 3D structureKappa-type opioid receptorP34975Rattus norvegicusPredicted (SEA)173.215
Click to view 3D structureSubstance-P receptorP14600Rattus norvegicusPredicted (SEA)127.517
Nociceptin receptor structureClick to view 3D structureNociceptin receptorP41146HumansPredicted (SEA)138.416
Gastrin/cholecystokinin type B receptor structureClick to view 3D structureGastrin/cholecystokinin type B receptorP32239HumansPredicted (SEA)133.511
Click to view 3D structureKappa-type opioid receptorP33534Mus musculusPredicted (SEA)142.386
Solute carrier family 15 member 1 structureClick to view 3D structureSolute carrier family 15 member 1P46059HumansPredicted (SEA)33.1638
Click to view 3D structureMu-opioid receptorQ8CGM4Cavia porcellusPredicted (SEA)88.281
Click to view 3D structureNociceptin receptorP47748Cavia porcellusPredicted (SEA)39.4696
Aminopeptidase N structureClick to view 3D structureAminopeptidase NP15144HumansPredicted (SEA)154.219
Click to view 3D structureUncharacterized proteinF1N083Bos taurusPredicted (SEA)125.337
Click to view 3D structureCytosol aminopeptidaseP28838HumansPredicted (SEA)94.5868
Click to view 3D structureAminopeptidase NP15145Sus scrofaPredicted (SEA)122.379
Click to view 3D structureCytosol aminopeptidaseP00727Bos taurusPredicted (SEA)88.4367
Click to view 3D structureCytosol aminopeptidaseP28839Sus scrofaPredicted (SEA)29.972
Click to view 3D structureAminopeptidase BO09175Rattus norvegicusPredicted (SEA)38.7689
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available